During the last 2 years, opioid-related deaths increased by 118%


Dose-controlled prescription drug delivery allows pharmacists to program ZICOH to dispense the medication dosage type, amount, and frequency according to the health care provider’s orders. This feature ensures medication adherence, reducing the risk of overdose and addiction.


Integrable authentication features, such as fingerprint authorization and facial recognition, help prevent prescription drugs, especially those more likely to lead to misuse or addiction, from ending up in the wrong hands.

Improve Safety + Compliance

Prescription drugs are the safest and most effective when they are taken as prescribed by the patient for whom they are intended. With a tamper-resistant design and programmable features like medication reminders, ZICOH makes medication adherence easier than ever.

ZICOH's Milestones

May 2020

The U.S. Patent and Trademark Office (USPTO) acknowledged that it believed ZICOH qualified for a patent.

August 10, 2021

The USPTO granted ZICOH technology its first patent (No. 11,083,850), recognizing ZICOH as a dose control-controlled medication delivery device

August 17, 2021

One week later, ZICOH technology received its second patent (No. US 11,090,449), securing ZICOH's rights as a smart inhaler device featuring automated dose delivery, measurement, and management of medications.

March 2022

ZICOH Receives Allowance For Third US Patent

ZICOH receives a US patent allowance that will grant the device rights as a secure, smart dosing system with automated delivery, measurement, and management for pills.


ZICOH Awaits Additional Patents